comparemela.com

Latest Breaking News On - Douglas thomson - Page 13 : comparemela.com

City of Glasgow College's upskilling courses click with Scotland's workforce

Thanks to funding that enables firms to upskill employees, City of Glasgow College has recently been able to deliver 1800 courses, ranging from…

Glasgow
Glasgow-city
United-kingdom
Scotland
Douglas-thomson
Leeann-clulow
College-principal-paul-little
City-of-glasgow-college
Flexible-workforce-development-fund
Scottish-government
Glasgow-college
Flexible-workforce-development-fund-manager

Pneumagen Raises £3.8 million to Advance the Phase II Clinical Development of Neumifil, a Pan-antiviral, Intranasal Drug for the Prophylaxis and Treatment of Viral Respiratory Tract Infections (RTIs)

/PRNewswire/ Pneumagen, a clinical stage biotech company developing Neumifil, a pan-antiviral, intranasal drug for the prophylaxis and treatment of viral.

United-kingdom
London
City-of
Scotland
Cathal-friel
Frazer-hall
Pneumagen-neumifil
Thairm-bio-mark-bamforth
Thairm-bio
Douglas-thomson
Sandi-greenwood
Fujifilm

Pneumagen Raises £3.8 million to Advance the Phase II Clinical Development of Neumifil, a Pan-antiviral, Intranasal Drug for the Prophylaxis and Treatment of Viral Respiratory Tract Infections (RTIs)

/PRNewswire/ Pneumagen, a clinical stage biotech company developing Neumifil, a pan-antiviral, intranasal drug for the prophylaxis and treatment of viral.

United-kingdom
London
City-of
Scotland
Cathal-friel
Frazer-hall
Pneumagen-neumifil
Thairm-bio-mark-bamforth
Thairm-bio
Douglas-thomson
Sandi-greenwood
Fujifilm

Pneumagen Raises £3.8 million to Advance the Phase II Clinical Development of Neumifil, a Pan-antiviral, Intranasal Drug for the Prophylaxis and Treatment of Viral Respiratory Tract Infections (RTIs)

ST ANDREWS, Scotland, Jan. 19, 2022 /PRNewswire/ Pneumagen, a clinical stage biotech company developing Neumifil, a pan-antiviral, intranasal drug for the prophylaxis and treatment of viral

United-kingdom
London
City-of
Scotland
Cathal-friel
Frazer-hall
Prnewswire-pneumagen
Thairm-bio
Thairm-bio-mark-bamforth
Pneumagen-neumifil
Douglas-thomson
Sandi-greenwood

Pneumagen Raises £3.8M in Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United-kingdom
Scotland
Thairm-bio
Douglas-thomson
Fujifilm
United-kingdom-based
Open-orphan
Carbohydrate-binding-molecule
Influenza-virus
Respiratory-syncytial-virus

vimarsana © 2020. All Rights Reserved.